Company Overview and News

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-07 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-05 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

64
Top Analyst Upgrades and Downgrades: Agnico Eagle Mines, Ford, Marathon Petroleum, Roku, Spotify, Quest Diagnostics and More

2018-05-29 247wallst
The futures traded lower this Tuesday morning as investors start the holiday-shortened trading week with continued concerns over trade and additional overseas issues, including growing political instability in Italy. While the geopolitical issues have continued to dominate the headlines, all eyes this week will be focused on Friday, when the nonfarm payroll numbers for May are due to be released.
WFCNP DGX MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MPC MS.PRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN AEM WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS PRT F MS.PRI INFN MS.PRK ROKU TRI NANO PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-30 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-30 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. IRAN NOTICE

2018-04-27 sec.gov
IRAN NOTICE April 27, 2018 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549
PTR

2
PTR / PetroChina Co., Ltd. FORM 20-F

2018-04-27 sec.gov
FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-19 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-17 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER
PTR

0
PTR / PetroChina Co., Ltd. / BlackRock Inc. - null (Passive Investment)

2018-04-06 sec.gov
cne1000003w8_040518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) PETROCHINA COMPANY LIMITED -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) B01DNL9 -------------------------------------------------------- (SEDOL Number) March 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this co
PTR

0
PTR / PetroChina Co., Ltd. / BlackRock Inc. - null (Passive Investment)

2018-04-06 sec.gov
cne1000003w8_040518.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) PETROCHINA COMPANY LIMITED -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) B01DNL9 -------------------------------------------------------- (SEDOL Number) March 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this co
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-03 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-03-23 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

0
PTR / PetroChina Co., Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-03-22 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PTR

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to PTR / PetroChina Co., Ltd. on message board site Silicon Investor.

AU Optronics-AUO PCTR-Perceptronics
PetroChina (PTR) Alcatel Optronics (NASDAQ: ALAO)
PTR (PetroChina) ADR Perceptron (PRCP)
Perceptronics (PCTR) CPTX - COMPTRONIX CORP
RPTR-Repeater Technologies Jupiter Communications - JPTR
CUSIP: 71646E100